Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 External Neuromodulation Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global External Neuromodulation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global External Neuromodulation Overall Market Size
2.1 Global External Neuromodulation Market Size: 2021 VS 2028
2.2 Global External Neuromodulation Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top External Neuromodulation Players in Global Market
3.2 Top Global External Neuromodulation Companies Ranked by Revenue
3.3 Global External Neuromodulation Revenue by Companies
3.4 Top 3 and Top 5 External Neuromodulation Companies in Global Market, by Revenue in 2021
3.5 Global Companies External Neuromodulation Product Type
3.6 Tier 1, Tier 2 and Tier 3 External Neuromodulation Players in Global Market
3.6.1 List of Global Tier 1 External Neuromodulation Companies
3.6.2 List of Global Tier 2 and Tier 3 External Neuromodulation Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global External Neuromodulation Market Size Markets, 2021 & 2028
4.1.2 Transcutaneous Electrical Nerve Stimulation
4.1.3 Transcranial Magnetic Stimulation
4.1.4 Respiratory Electrical Stimulation
4.2 By Type - Global External Neuromodulation Revenue & Forecasts
4.2.1 By Type - Global External Neuromodulation Revenue, 2017-2022
4.2.2 By Type - Global External Neuromodulation Revenue, 2023-2028
4.2.3 By Type - Global External Neuromodulation Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global External Neuromodulation Market Size, 2021 & 2028
5.1.2 Spinal Cord Stimulation
5.1.3 Deep Brain Stimulation
5.1.4 Sacral Nerve Stimulation
5.1.5 Others
5.2 By Application - Global External Neuromodulation Revenue & Forecasts
5.2.1 By Application - Global External Neuromodulation Revenue, 2017-2022
5.2.2 By Application - Global External Neuromodulation Revenue, 2023-2028
5.2.3 By Application - Global External Neuromodulation Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global External Neuromodulation Market Size, 2021 & 2028
6.2 By Region - Global External Neuromodulation Revenue & Forecasts
6.2.1 By Region - Global External Neuromodulation Revenue, 2017-2022
6.2.2 By Region - Global External Neuromodulation Revenue, 2023-2028
6.2.3 By Region - Global External Neuromodulation Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America External Neuromodulation Revenue, 2017-2028
6.3.2 US External Neuromodulation Market Size, 2017-2028
6.3.3 Canada External Neuromodulation Market Size, 2017-2028
6.3.4 Mexico External Neuromodulation Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe External Neuromodulation Revenue, 2017-2028
6.4.2 Germany External Neuromodulation Market Size, 2017-2028
6.4.3 France External Neuromodulation Market Size, 2017-2028
6.4.4 U.K. External Neuromodulation Market Size, 2017-2028
6.4.5 Italy External Neuromodulation Market Size, 2017-2028
6.4.6 Russia External Neuromodulation Market Size, 2017-2028
6.4.7 Nordic Countries External Neuromodulation Market Size, 2017-2028
6.4.8 Benelux External Neuromodulation Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia External Neuromodulation Revenue, 2017-2028
6.5.2 China External Neuromodulation Market Size, 2017-2028
6.5.3 Japan External Neuromodulation Market Size, 2017-2028
6.5.4 South Korea External Neuromodulation Market Size, 2017-2028
6.5.5 Southeast Asia External Neuromodulation Market Size, 2017-2028
6.5.6 India External Neuromodulation Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America External Neuromodulation Revenue, 2017-2028
6.6.2 Brazil External Neuromodulation Market Size, 2017-2028
6.6.3 Argentina External Neuromodulation Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa External Neuromodulation Revenue, 2017-2028
6.7.2 Turkey External Neuromodulation Market Size, 2017-2028
6.7.3 Israel External Neuromodulation Market Size, 2017-2028
6.7.4 Saudi Arabia External Neuromodulation Market Size, 2017-2028
6.7.5 UAE External Neuromodulation Market Size, 2017-2028
7 Players Profiles
7.1 Medtronic, Inc. (US)
7.1.1 Medtronic, Inc. (US) Corporate Summary
7.1.2 Medtronic, Inc. (US) Business Overview
7.1.3 Medtronic, Inc. (US) External Neuromodulation Major Product Offerings
7.1.4 Medtronic, Inc. (US) External Neuromodulation Revenue in Global Market (2017-2022)
7.1.5 Medtronic, Inc. (US) Key News
7.2 Boston Scientific Corporation (US)
7.2.1 Boston Scientific Corporation (US) Corporate Summary
7.2.2 Boston Scientific Corporation (US) Business Overview
7.2.3 Boston Scientific Corporation (US) External Neuromodulation Major Product Offerings
7.2.4 Boston Scientific Corporation (US) External Neuromodulation Revenue in Global Market (2017-2022)
7.2.5 Boston Scientific Corporation (US) Key News
7.3 St. Jude Medical, Inc. (US)
7.3.1 St. Jude Medical, Inc. (US) Corporate Summary
7.3.2 St. Jude Medical, Inc. (US) Business Overview
7.3.3 St. Jude Medical, Inc. (US) External Neuromodulation Major Product Offerings
7.3.4 St. Jude Medical, Inc. (US) External Neuromodulation Revenue in Global Market (2017-2022)
7.3.5 St. Jude Medical, Inc. (US) Key News
7.4 Synapse Biomedical, Inc. (US)
7.4.1 Synapse Biomedical, Inc. (US) Corporate Summary
7.4.2 Synapse Biomedical, Inc. (US) Business Overview
7.4.3 Synapse Biomedical, Inc. (US) External Neuromodulation Major Product Offerings
7.4.4 Synapse Biomedical, Inc. (US) External Neuromodulation Revenue in Global Market (2017-2022)
7.4.5 Synapse Biomedical, Inc. (US) Key News
7.5 Nevro Corporation (US)
7.5.1 Nevro Corporation (US) Corporate Summary
7.5.2 Nevro Corporation (US) Business Overview
7.5.3 Nevro Corporation (US) External Neuromodulation Major Product Offerings
7.5.4 Nevro Corporation (US) External Neuromodulation Revenue in Global Market (2017-2022)
7.5.5 Nevro Corporation (US) Key News
7.6 Neurosigma, Inc. (US)
7.6.1 Neurosigma, Inc. (US) Corporate Summary
7.6.2 Neurosigma, Inc. (US) Business Overview
7.6.3 Neurosigma, Inc. (US) External Neuromodulation Major Product Offerings
7.6.4 Neurosigma, Inc. (US) External Neuromodulation Revenue in Global Market (2017-2022)
7.6.5 Neurosigma, Inc. (US) Key News
7.7 Neuropace, Inc. (US)
7.7.1 Neuropace, Inc. (US) Corporate Summary
7.7.2 Neuropace, Inc. (US) Business Overview
7.7.3 Neuropace, Inc. (US) External Neuromodulation Major Product Offerings
7.7.4 Neuropace, Inc. (US) External Neuromodulation Revenue in Global Market (2017-2022)
7.7.5 Neuropace, Inc. (US) Key News
7.8 Neuronetics, Inc. (US)
7.8.1 Neuronetics, Inc. (US) Corporate Summary
7.8.2 Neuronetics, Inc. (US) Business Overview
7.8.3 Neuronetics, Inc. (US) External Neuromodulation Major Product Offerings
7.8.4 Neuronetics, Inc. (US) External Neuromodulation Revenue in Global Market (2017-2022)
7.8.5 Neuronetics, Inc. (US) Key News
7.9 Cyberonics, Inc. (US)
7.9.1 Cyberonics, Inc. (US) Corporate Summary
7.9.2 Cyberonics, Inc. (US) Business Overview
7.9.3 Cyberonics, Inc. (US) External Neuromodulation Major Product Offerings
7.9.4 Cyberonics, Inc. (US) External Neuromodulation Revenue in Global Market (2017-2022)
7.9.5 Cyberonics, Inc. (US) Key News
7.10 BioControl Medical (Israel)
7.10.1 BioControl Medical (Israel) Corporate Summary
7.10.2 BioControl Medical (Israel) Business Overview
7.10.3 BioControl Medical (Israel) External Neuromodulation Major Product Offerings
7.10.4 BioControl Medical (Israel) External Neuromodulation Revenue in Global Market (2017-2022)
7.10.5 BioControl Medical (Israel) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer